GL1X · GenesisL1 explorer

MolNFT v1 · #101812 · protein

Kinase domain of csrc in complex with a substituted pyrazolopyrimidine

4O2P · Proto-oncogene tyrosine-protein kinase src: “Kinase domain of csrc in complex with a substituted pyrazolopyrimidine”. X-ray diffraction, 1 ligand (11V), 7 pockets (best druggability 0.68). MolNFT v1 #101812 on GenesisL1: 3D…

PDB
4O2P
Type
protein
Length
530 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
11V
Pockets
7 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26543% helix, 17% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26540% helix, 18% strandP00523

Ligands and binding sites

  • 11V · 1-[(2R)-2-chloro-2-phenylethyl]-6-{[2-(morpholin-4-yl)ethyl]sulfanyl}-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16160.680.775611V
24100.650.785011V
34220.620.7742empty
4710.490.8418empty
51100.360.7420empty

Interfaces

1 interface between chains.

  • A–B · 364 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4O2P · Kinase domain of cSrc in complex with a substituted pyrazolopyrimidine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.